Oral and cutaneous angioproliferative diseases: histopathologic correlations and expression of angiogenic mediators / Distúrbios angioproliferativos bucais e cutâneos: correlações histopatológicas e expressão de mediadores angiogênicos
AUTOR(ES)
Maria Renata Sales Nogueira Costa
DATA DE PUBLICAÇÃO
2006
RESUMO
The oral mucosa and the skin may present proliferative vascular diseases with varied biological behavior. To classify such lesions, pathogenic criteria were adopted in specific groups of vascular lesions. The objective of this retrospective study was to characterize the main oral vascular lesions, comparing them with the same types of cutaneous lesions. The histopathologic findings were compared, as well as the endothelial expression of basic fibroblastic growth factor (FGFb) and p75 neurotrophin receptor (p75NTR). Paraffin embedded specimens were purchased and divided, according to microscopic diagnostic, into six groups: (I) venous malformations; (II) lymphatic malformations; (III) pyogenic granulomas; (IV) capillary hemangiomas; (V) arteriovenous hemangiomas; (VI) Kaposi sarcomas. Each group was divided in two subgroups of oral and cutaneous location. The microscopic data demonstrated that oral and cutaneous vascular lesions, in our sample, are similar and they can be classified under the same parameters. However, some groups presented differences related to maturation stage, incidence, and expression FGFb and p75NTR. These differences allowed us to conclude that the evolution of angiogenic process inside oral mucosa and in the skin, not necessarily is mediated by the same biological factors. Such differences open perspectives for future researches and therapeutic approaches, based on molecular technologies.
ASSUNTO(S)
hemangioma mucosa oral patologia bucal sarcoma granuloma
Documentos Relacionados
- Expressão de fatores angiogênicos em corpo lúteo cíclico e superovulado de búfalas
- Mosaicismos cutaneos: conceitos, padroes e classificacoes
- Substitutos cutâneos: conceitos atuais e proposta de classificação
- Ação da jararagina na expressão gênica e protéica de mediadores pró-inflamatórios por células endoteliais humanas.
- Mutações BRAF em melanomas cutâneos: nenhuma correlação com fatores prognósticos e sobrevida global